Targeting backup DNA repair in cancer.
New research shows that DNA polymerase θ is a key player in PARP-mediated DNA damage repair and essential for the survival of cancer cells where homologous recombination is compromised. Polθ could be a biomarker for PARP-inhibitor response, and is a potential therapeutic target for overcoming resistance to these drugs.